Utilization of Multiple Sclerosis Therapies in the Middle East Over a Decade: 2009-2018.

Nahid MoradiSifat SharminCharles MalpasSerkan OzakbasVahid ShaygannejadMurat TerziCavit BozBassem YamoutRecai TurkogluRana KarabudakSherif HamdyAysun SoysalAyşe AltıntaşJihad InshasiTalal Al-HarbiRaed AlroughaniTomas Kalinciknull null

Published in: CNS drugs (2021)

Patients in the Middle East enrolled in a large multinational registry are representative of the general MS population. The spectrum of therapies used in the individual countries, however, is highly variable. Further studies that include rural and non-academic practices are needed to enhance our understanding of the MS cohorts in the Middle East.

Keyphrases

multiple sclerosis
end stage renal disease
mass spectrometry
ms ms
ejection fraction
newly diagnosed
chronic kidney disease
healthcare
primary care
peritoneal dialysis
white matter
cross sectional